Munoz et al reported predictors of a medication-associated altered mental status in a hospitalized patient. These can help to identify a patient who should be monitored more closely for this adverse drug effect. The authors are from the Food and Drug Administration, University of Florida, University of Utah, and German Cancer Research Center.
